Article tools
Author information

Research Article

BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells.

I Giardino, D Edelstein and M Brownlee

Department of Medicine, Albert Einstein College of Medicine, New York, USA.

Published March 15, 1996

Hyperglycemia rapidly induces an increase in intracellular advanced glycation end products (AGEs) in bovine endothelial cells, causing an alteration in bFGF activity (Giardino, I., D. Edelstein, and M. Brownlee. 1994. J. Clin. Invest. 94:110-117). Because sugar or sugar-adduct autoxidation is critical for AGE formation in vitro, we evaluated the role of reactive oxygen species (ROS) in intracellular AGE formation, using bovine aortic endothelial cells. 30 mM glucose increased intracellular ROS formation by 250% and lipid peroxidation by 330%, while not affecting ROS in the media. In cells depleted of glutathione, intracellular AGE accumulation increased linearly with ROS generation as measured by immunoblotting and the fluorescent probe DCFH (AGE 0.258-3.531 AU* mm/5x10(4) cells, DCF 57-149 mean AU, r = .998, P < .002). Deferoxamine, alpha-tocopherol, and dimethylsulfoxide each inhibited hyperglycemia-induced formation of both ROS and AGE. To differentiate an effect of ROS generation on AGE formation from an effect of more distal oxidative processes, GM7373 endothelial cell lines were generated that stably expressed the peroxidation-suppressing proto-oncogene bcl-2. bcl-2 had no effect on hyperglycemia-induced intracellular ROS formation. In contrast, bcl-2 expression decreased both lipid peroxidation (100% at 3 h and 29% at 168 h) and AGE formation (55% at 168 h). These data show that a ROS-dependent process plays a central role in the generation of intracellular AGEs, and that inhibition of oxidant pathways prevents intracellular AGE formation.

Articles that cite
this article:

Oxidative stress, AGE, and atherosclerosis
E Schleicher, U Friess
Kidney Int [CrossRef]

Nichtenzymatische Glykierung und oxidativer Streß bei chronischen Erkrankungen und Diabetes mellitus
Peter P. Nawroth, Angelika Bierhaus, Gabriele E. Vogel, Marion A. Hofmann, Martina Zumbach, Peter Wahl, Reinhard Ziegler
Med Klin 94(1):29. [CrossRef]

Naturally occurring flavonoids attenuate high glucose-induced expression of proinflammatory cytokines in human monocytic THP-1 cells
Chi-Hao Wu, Cheng-Feng Wu, Hsiao-Wen Huang, Ya-Chien Jao, Gow-Chin Yen
Mol Nutr Food Res 53(8):984. [CrossRef]

The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation
Melissa M. Anderson, Jesús R. Requena, Jan R. Crowley, Suzanne R. Thorpe, Jay W. Heinecke
J Clin Invest 104(1):103. [CrossRef]

Hyperglycemic oxoaldehyde, glyoxal, causes barrier dysfunction, cytoskeletal alterations, and inhibition of angiogenesis in vascular endothelial cells: aminoguanidine protection
Sean M. Sliman, Timothy D. Eubank, Sainath R. Kotha, M. Lakshmi Kuppusamy, Shariq I. Sherwani, Elizabeth Susan O’Connor Butler, Periannan Kuppusamy, Sashwati Roy, Clay B. Marsh, David M. Stern
MOL CELL BIOCHEM [CrossRef]

Cyclosporine A regulate oxidative stress-induced apoptosis in cardiomyocytes: mechanisms via ROS generation, iNOS and Hsp70
Huei-Wen Chen, Chiang-Ting Chien, Sung-Liang Yu, Yuan-Teh Lee, Wen-Jone Chen
Br J Pharmacol 137(6):771. [CrossRef]

Therapeutic potential of endothelin receptor antagonists in diabetes
Subrata Chakrabarti, Mark Cukiernik, Suranjana Mukherjee, Shali Chen
Expert Opin Invest Drugs 9(12):2873. [CrossRef]

Effects of OPB-9195, anti-glycation agent, on experimental diabetic neuropathy
R. Wada, Y. Nishizawa, N. Yagihashi, M. Takeuchi, Y. Ishikawa, K. Yasumura, M. Nakano, S. Yagihashi
Eur J Clin Invest 31(6):513. [CrossRef]


Dominique Bonnefont-rousselot
Curr Opin Clin Nutr Metab Care 5(5):561. [CrossRef]

A hydroxyl radical–like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease
Subramaniam Pennathur, Janice D. Wagner, Christiaan Leeuwenburgh, Kenneth N. Litwak, Jay W. Heinecke
J Clin Invest 107(7):853. [CrossRef]

Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications
Elena Beltramo, Elena Berrone, Sonia Tarallo, Massimo Porta
Acta Diabetol 45(3):131. [CrossRef]

Advanced glycation end products and diabetic foot disease
Maya S.P. Huijberts, Nicolaas C. Schaper, Casper G. Schalkwijk
Diabetes Metab Res Rev 24(s1):S19. [CrossRef]

HUVECs from newborns with a strong family history of diabetes show diminished ROS synthesis in the presence of high glucose concentrations
Noé Alvarado-vásquez, Araceli Páez, Estrella Zapata, Susana Alcázar-leyva, Edgar Zenteno, Felipe Massó, Luis F. Montaño
Diabetes Metab Res Rev 23(1):71. [CrossRef]

New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells
Michael A. Sirover
J Cell Biochem 95(1):45. [CrossRef]

Effect of Posttraumatic Hyperglycemia on Contusion Volume and Neutrophil Accumulation after Moderate Fluid-Percussion Brain Injury in Rats
Kosaku Kinoshita, Susan Kraydieh, Ofelia Alonso, Nariyuki Hayashi, W. Dalton Dietrich
J Neurotrauma 19(6):681. [CrossRef]

Influence of alpha-lipoic acid on lipid peroxidation and antioxidant defence system in blood of insulin-resistant rats
V. Thirunavukkarasu, C. V. Anuradha
Diabetes Obes Metab 6(3):200. [CrossRef]

Role of oxidative stress in advanced glycation end product-induced mesangial cell activation
Mark A. Lal, Hjalmar Brismar, Ann-Christine Eklof, Anita Aperia
Kidney Int 61(6):2006. [CrossRef]

Advanced glycation end products and mortality in hemodialysis patients
Susanne B. Schwedler, Thomas Metzger, Reinhard Schinzel, Christoph Wanner
Kidney Int 62(1):301. [CrossRef]

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy
Subrata Chakrabarti, Mark Cukiernik, Denise Hileeto, Terry Evans, Shali Chen
Diabetes Metab Res Rev 16(6):393. [CrossRef]

Formation of advanced glycation end-product-modified superoxide dismutase-1 (SOD1) is one of the mechanisms responsible for inclusions common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutation, and transgenic mice expressing human SOD1 gene mutation
Shinsuke Kato, Kenji Nakashima, Seikoh Horiuchi, Ryoji Nagai, Don W. Cleveland, Jian Liu, Asao Hirano, Miki Takikawa, Masako Kato, Imaharu Nakano
21(1):67. [CrossRef]

The missing link: A single unifying mechanism for diabetic complications
Takeshi Nishikawa, Diane Edelstein, Michael Brownlee
Kidney Int 58(suppl. 77):26. [CrossRef]

B cell leukaemia/lymphoma-2 protein concentrations during normal pregnancy
M. Buemi, A. Allegra, F. Corica, R. D'anna, A. Ruello, V. M. Jasonni
BJOG An Internal Journal of Obs Gyn 107(1):133. [CrossRef]


Klaus Witte, Ina Reitenbach, Kerstin Stolpe, Lothar Schilling, Michael Kirchengast, Bjorn Lemmer
J Cardiovasc Pharmacol 41(6):890. [CrossRef]

Oxidative stress in keratinocytes as an etiopathogenetic factor of psoriasis
V. N. Shilov, V. I. Sergienko
Bull Exp Biol Med 129(4):309. [CrossRef]

Atherosclerosis and arteriosclerosis in chronic renal failure
Gérard M London, Tilman B Drüeke
Kidney Int 51(6):1678. [CrossRef]

Glycation damage targets glutamate dehydrogenase in the rat liver mitochondrial matrix during aging
Maud Hamelin, Jean Mary, Michal Vostry, Bertrand Friguet, Hilaire Bakala
FEBS J 274(22):5949. [CrossRef]

Superoxide dismutase analog (Tempol: 4-hydroxy-2, 2, 6, 6-tetramethylpiperidine 1-oxyl) treatment restores erectile function in diabetes-induced impotence
T Ogishima, T Tokizane, K Kawamoto, T Kawakami, S Urakami, H Hirata, Y Tanaka, K Nakajima, H Enokida, H Shiina
Int J Impot Res [CrossRef]